What is Havana Syndrome, And Why Is It Making Headlines Again in 2026

Illustration shows a human head with highlighted brain activity linked to Havana Syndrome symptoms

In January 2026, Havana Syndrome is back in the headlines because reporting says the U.S. government has obtained and tested a portable device capable of generating pulsed radio waves, a mechanism long suspected in the case.

Public details remain limited, and U.S. intelligence agencies have not concluded who, if anyone, used such technology.

Still, the optics matter: for the first time in years, the debate is no longer only about symptoms and theories, but about a physical device investigators believe could plausibly produce the reported neurological effects.

That shift explains why the story is trending again, especially amid heightened U.S. concerns over covert, deniable threats to Americans abroad.

At the same time, the strongest official evidence points in a different direction.

The Intelligence Communityโ€™s latest unclassified assessment, updated through December 2024 and released in January 2025, concludes it is very unlikely or unlikely that a foreign actor caused the reported incidents.

NIH-led clinical research published in 2024 found that while affected individuals reported severe symptoms, there was no consistent MRI-detectable brain injury or biological abnormality across cases.

What Havana Syndrome is Called Now, and Why That Matters

Illustration shows a government building with wave patterns symbolizing anomalous health incidents linked to Havana Syndrome
Source: Youtube/Screenshot, Havana Syndrome is now classified as Anomalous Health Incidents, a label that reflects uncertainty rather than a single cause

Inside government documents, โ€œHavana Syndromeโ€ is increasingly treated as a public label for what agencies call Anomalous Health Incidents (AHIs). That bureaucratic shift matters because it quietly signals uncertainty: AHI is an incident category, not a single confirmed diagnosis with a single proven cause, according to DNI.

In practice, that means one reported โ€œAhi eventโ€ could later be explained as a vestibular migraine, another as a conventional illness plus stress, another as an environmental exposure, and a residual subset might remain unexplained.

The category approach is also why debates have become so circular: people are arguing about โ€œthe causeโ€ of something that may not be one thing.

When this first surfaced publicly in 2016 among U.S. Embassy personnel in Havana, the story took on a crisp narrative shape: sudden onset, strange sensory experience, lingering neurological complaints, possible hostile action.

Over time, the global distribution of reports (and the variability in what individuals experienced) turned the problem into something harder to pin down. If your baseline assumption is โ€œone weapon, one actor, one mechanism,โ€ the data can feel frustrating.

If your baseline assumption is โ€œa bucket of different events labeled the same way,โ€ the same data starts to look more plausible, but politically unsatisfying.

The January 2026 Development: The โ€œPortable Deviceโ€ Storyline, and What is Known so Far


The current wave of attention comes from reporting (summarized widely, including in Scientific American and local outlets carrying CNN material) that the Department of Defense has been testing a device that investigators believe could be linked to Havana Syndrome.

The descriptions that keep recurring are the ones that make headlines: pulsed radio waves, portable or backpack-sized, and acquired via an undercover operation (with reporting also mentioning the Department of Homeland Security in connection with the purchase). Those details, if accurate, do not prove the device caused the historical cases.

But they do change the rhetorical terrain: it shifts the debate from โ€œis a directed-energy device even plausible in the real worldโ€ to โ€œwhat did tests show, what could it do, and can any real incidents be linked to it?โ€

Two cautions are essential if you want to treat this like a serious story rather than a thriller plot. First, capability is not attribution. A device that can emit pulsed RF energy is not proof that it was deployed against U.S. personnel.

Second, even if a device can produce discomfort or transient effects in controlled settings, the hard part is matching it to the contested claims that shaped the Havana Syndrome narrative: sudden onset at specific locations, consistent symptom clusters, and sometimes long-lasting impairment. That requires event-level evidence, not just general plausibility.

The Official Record: What U.S. Intelligence And U.S. Medicine Have Concluded So Far

CIA headquarters seal shown in a report discussing intelligence and medical assessments of Havana Syndrome
Source: Youtube/Screenshot, U.S. intelligence says foreign involvement is very unlikely, with disagreement over only a few cases

If you strip away the noise, the U.S. governmentโ€™s most authoritative public signals come from two channels: intelligence community assessments and clinical research.

1) Intelligence Community: โ€œVery Unlikelyโ€ Foreign Actor, With Documented Dissent on a Small Subset

The ODNIโ€™s unclassified โ€œUpdated Assessment of Anomalous Health Incidents, as of December 2024โ€ states that IC components continue to assess it is โ€œvery unlikelyโ€ or โ€œunlikelyโ€ that any foreign actor caused the reported events.

It also notes that some components hold different views about whether a foreign actor might have played a role in a small number of events, which is why the debate never fully dies.

Reutersโ€™ coverage of the 2025 release emphasized the same basic structure: most agencies say โ€œvery unlikely,โ€ while one agency judged a โ€œroughly even chanceโ€ for a small subset.

2) NIH and Peer-reviewed Work: Severe Symptoms, But No Consistent MRI-Detectable Injury Signature

In March 2024, the NIH publicly summarized results from studies of affected personnel: participants reported severe symptoms, but the research found no evidence of MRI-detectable brain injury or consistent biological abnormalities.

The peer-reviewed publication available via PubMed Central frames the same bottom line: when compared with controls, the study did not find a consistent pattern that would validate a single injury mechanism across cases.

This does not mean patients were โ€œfineโ€ or imagining symptoms; it means the strongest claim often made in popular coverage, a consistent brain injury footprint, did not hold up in that dataset with those methods.

A Timeline That Shows Why The Story Keeps Snapping Back

A timeline is useful here because the โ€œdeviceโ€ news makes more sense when you see how the U.S. governmentโ€™s interpretation has swung over time.

Year Key event or finding Why did it change the debate
2016โ€“2017 Cluster of reports in Havana among U.S. personnel Establishes the โ€œsudden onset, localized eventโ€ narrative
2020 The National Academies report says directed, pulsed RF energy is a plausible mechanism for some cases Gives the directed-energy hypothesis mainstream institutional backing, while still not proving it
2022 State Department releases redacted JASON report analyzing hypotheses and data limits Pushes back on broad claims, stresses data quality and constraints, and argues many incidents have mundane explanations
2023 ODNI ICA says foreign adversary involvement is very unlikely Largest official โ€œdownshiftโ€ on the foreign-attack narrative (later reaffirmed)
2024 NIH/JAMA work: no consistent MRI-detectable injury signature Weakens the โ€œconsistent brain injuryโ€ framing as a general explanation
2024 GAO: patient communication and monitoring problems across pathways Shifts public focus toward care, access, and system failures, regardless of cause
Jan 2026 Reporting: Pentagon testing a portable pulsed RF device acquired covertly Re-ignites directed-energy attention by making it about hardware again

What the National Academies And JASON Actually Said, And Why Both Are Still Cited in 2026

Illustration shows a person experiencing distress as wave patterns reference Havana Syndrome research debates
Source: Youtube/Screenshot, National Academies saw directed RF as possible, while JASON found evidence too weak for firm conclusions

One reason Havana Syndrome arguments get so heated is that both โ€œsidesโ€ can cite serious institutions. The disagreement is less about whether the symptoms are real and more about whether a specific mechanism is supported by the available record.

The National Academies report (2020) is often cited because it explicitly said that, after considering possible mechanisms, directed, pulsed RF energy was a plausible explanation for certain distinctive acute features.

The Academies also emphasized the human cost and the need for coordinated investigation. That language has been repeatedly recycled in media and advocacy because it is one of the few formal documents that gives directed energy a central role.

The JASON study released by the State Department in 2022 is often cited by skeptics because it stresses limitations: small numbers, inconsistent data products, and lack of a comparable background population.

In a story where people want a single culprit, JASONโ€™s emphasis on โ€œdata quality and alternative explanationsโ€ reads like deflation, but it is also a reminder that you cannot reverse-engineer a covert attack narrative from symptoms alone.

A fair reading of both is: the Academies argued directed pulsed RF should be taken seriously as a mechanism for a subset, while JASON argued the available data do not support strong claims and that many incidents likely have more ordinary causes. Neither document gives you what the public most wants: a definitive mechanism plus attribution.

The Policy Reality: Congress, Compensation, And Why the U.S. System Treats This as Real Even When The Cause is Disputed

 

View this post on Instagram

 

A post shared by 25BWB (@25_bwb)

Even as intelligence agencies have leaned away from a foreign campaign explanation, Congress and executive agencies have moved in the opposite direction on one practical point: people reporting AHIs should not be left to fight for care and benefits in a fog of uncertainty.

The HAVANA Act of 2021 created a compensation pathway for certain U.S. personnel with qualifying brain injuries tied to these incidents, and agencies have issued rules and implementation guidance over time.

In 2024, the Department of Defense published an implementation rule that aligns its payment scheme with the State Departmentโ€™s approach, reflecting the reality that the government expects claims, disputes, and adjudications to continue.

What Patients Reported About the System: The GAOโ€™s View

Woman holding her head with visual rings suggesting symptoms reported in Havana Syndrome cases
Source: Youtube/Screenshot, GAO found inconsistent care and support for Havana Syndrome patients

The GAO report published in July 2024 is blunt about what patients experienced. Based on interviews with AHI patients, GAO describes challenges such as inconsistent support from home agencies, limited information, and unclear points of contact when entering the Military Health System, and difficulties navigating referrals and monitoring.

This kind of finding is not sensational, but it is consequential because it shapes whether affected personnel trust the system and whether claims are handled consistently.

The most important thing to understand here is that โ€œcause uncertaintyโ€ does not neutralize harm.

A person can be debilitated by dizziness, headaches, tinnitus, insomnia, and cognitive dysfunction without the government being able to prove a single mechanism. In practice, that means the U.S. system has to operate on two tracks: scientific investigation and patient support.

Oversight reports suggest that the second track has been uneven, which is why Havana Syndrome remains politically alive even when intelligence assessments trend skeptical.

Five Questions That Decide Whether This Becomes a National Security Scandal or a Long Medical-Policy Fight

The reason this story keeps returning is that it sits at the intersection of intelligence culture and medicine. In the U.S., both worlds have strong incentives to avoid admitting uncertainty, but Havana Syndrome forces uncertainty into public view.

Here are the questions that actually matter now, and why they are the ones you will see driving coverage through 2026.

Question Why it matters in the U.S. right now What the public record currently supports
Is there a single cause behind most cases? A single cause would justify a โ€œcountermeasuresโ€ posture and a clean narrative NIH and IC records support heterogeneity and uncertainty more than a single unified cause
Could directed pulsed RF explain a subset? This is the โ€œweaponโ€ hypothesis that drives fear and policy National Academies treated it as plausible for some; JASON urged caution and emphasized constraints and data limits
Did a foreign actor run a campaign? This is the threshold for major retaliation logic. ODNI says very unlikely or unlikely in general; Reuters notes limited dissent for a small subset
Are patients being supported fairly? Compensation and care become the political battleground when causation is unclear GAO documents access and communication challenges in the care pipeline
Will the โ€œdeviceโ€ story produce verifiable evidence? Without verifiable details, it becomes another narrative spike Reporting says testing is ongoing; official technical details remain limited publicly

FAQ

Can the device reliably produce the reported acute sensations without leaving obvious signatures?
A core tension in Havana Syndrome is the mismatch between vivid reports of sudden onset and the lack of consistent objective biomarkers in large studies. NIHโ€™s findings make it harder to argue for a uniform injury signature. A device story re-opens the question of whether certain exposures could produce intense transient symptoms that do not leave a consistent MRI footprint. That is a scientific question, not a political one, and it is not resolved by headlines.
What does โ€œtested for over a yearโ€ actually mean?
The phrase suggests systematic evaluation, but the public does not know the test protocol, endpoints, or what was ruled in or out. Was the deviceโ€™s output independently measured? Under what conditions? Is there a known exposure profile that matches plausible real-world scenarios, like hotel rooms and embassy housing? Until that detail is public or leaked credibly, the device remains an accelerant for speculation, not a closure mechanism.
Does any incident have event-level evidence that links back to this device or its components?
This is the hardest part and the one intelligence agencies keep circling. The ODNI assessment emphasizes that reporting points away from foreign actors as a general explanation. For the device story to change that posture, you would need case-by-case linkage, procurement, and operator trails, signals collection, or other attribution-grade evidence. Otherwise, the device story can coexist with โ€œvery unlikely foreign actorโ€ assessments, because the existence of a capability does not prove its use.ย 

Bottom Line

@cnn Former CIA agent “Adam” described his experience as Havana Syndrome’s ‘patient zero’ to CNN’s Jim Sciutto, and said he believes the government has downplayed the attack since 2016. The US has spent over a year testing a device purchased in an undercover operation that some investigators think could be the cause of a series of mysterious ailments impacting US spies, diplomats and troops. #cnn #havanasyndrome โ™ฌ original sound – CNN

Solid, as of the current public record, means three things. One, AHIs involve real and sometimes debilitating symptoms in a subset of personnel, and the U.S. government treats the category as serious.

Two, the Intelligence Communityโ€™s updated unclassified assessment continues to say it is very unlikely or unlikely that a foreign actor caused the reported events overall, while acknowledging limited disagreement on a small subset.

Three, NIH-led clinical work found severe symptoms but no consistent MRI-detectable brain injury signature or uniform biological abnormality pattern across the studied cohort.

Contested is everything that requires a leap from plausibility to proof: whether directed energy explains a meaningful subset, whether any specific actor did it, and whether any newly discussed device can be tied to real events with attribution-grade evidence.